Increase in plasmacytoid and myeloid dendritic cells by progenipoietin-1, a chimeric Flt-3 and G-CSF receptor agonist, in SIV-Infected rhesus macaques

Human Immunology

Volumn 65, Issue 4, 2004, Pages 303-316

  Koopman, Gerrit ^a   Niphuis, Henk ^a   Haaksma, Anton G M ^a   Farese, Ann M ^b   Casey, Dan B ^b   Kahn, Larry E ^c   Mann, Dean ^b   MacVittie, Thomas J ^b   Woulfe, Susan L ^c   Heeney, Jonathan L ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UNIVERSITY OF MARYLAND   (United States)

^c Pharmacia Research   (United States)

Author keywords

AIDS; dendritic cell; Flt 3; G CSF; HIV; ProGP

Indexed keywords

ANTIBODY; CD11B ANTIGEN; CD123 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHIMERIC PROTEIN; FLT3 LIGAND; GLYCOPROTEIN P 15095; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR AGONIST; IMMUNOMODULATING AGENT; PROGENIPOIETIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BLOOD CELL; BONE MARROW CELL; CONTROLLED STUDY; DENDRITIC CELL; EXPERIMENTAL INFECTION; IMMUNOTHERAPY; LEUKOCYTE; NONHUMAN; PLASMA; PLASMA CELL; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TIME SERIES ANALYSIS; VIRUS INFECTION; VIRUS LOAD;

EID: 11144354057     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.01.013     Document Type: Article

References (58)

1. McCune J.M. The dynamics of CD4+ T-cell depletion in HIV disease. Nature. 410:2001;974
2. McMichael A.J., Rowland-Jones S.L. Cellular immune responses to HIV. Nature. 410:2001;980
3. Macatonia S.E., Patterson S., Knight S.C. Suppression of immune responses by dendritic cells infected with HIV. Immunology. 67:1989;285
4. Macatonia S.E., Lau R., Patterson S., Pinching A.J., Knight S.C. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology. 71:1990;38
5. Zimmer M.I., Larregina A.T., Castillo C.M., Capuano S. 3rd, Falo L.D. Jr, Murphey-Corb M., Reinhart T.A., Barratt-Boyes S.M. Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS. Blood. 99:2002;2859
6. Patterson S., Gross J., English N., Stockpoole A., Bedford P., Knight S.C. CD4 expression on dendritic cells and their infection by human immunodeficiency virus. J Gen Virol. 76:1995;1155
7. O'Doherty U., Steinman R.M., Peng M., Cameron P.U., Gezelter S., Kopeloff I., Swiggard W.J., Pope M., Bhardwaj N. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med. 178:1993;1067
8. O'Doherty U., Peng M., Gezelter S., Swiggard W.J., Betjes M., Bhardwaj N., Steinman R.M. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology. 82:1994;487
9. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 283:1999;1183
10. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 5:1999;919
11. Donaghy H., Pozniak A., Gazzard B., Qazi N., Gilmour J., Gotch F., Patterson S. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood. 98:2001;2574
12. Pacanowski J., Kahi S., Baillet M., Lebon P., Deveau C., Goujard C., Meyer L., Oksenhendler E., Sinet M., Hosmalin A. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood. 98:2001;3016
13. Chehimi J., Campbell D.E., Azzoni L., Bacheller D., Papasavvas E., Jerandi G., Mounzer K., Kostman J., Trinchieri G., Montaner L.J. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol. 168:2002;4796
14. Feldman S., Stein D., Amrute S., Denny T., Garcia Z., Kloser P., Sun Y., Megjugorac N., Fitzgerald-Bocarsly P. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin Immunol. 101:2001;201
15. Grassi F., Hosmalin A., McIlroy D., Calvez V., Debre P., Autran B. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. Aids. 13:1999;759
16. Pakker N.G., Notermans D.W., de Boer R.J., Roos M.T., de Wolf F., Hill A., Leonard J.M., Danner S.A., Miedema F., Schellekens P.T. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection a composite of redistribution and proliferation. Nat Med. 4:1998;208
17. Li T.S., Tubiana R., Katlama C., Calvez V., Ait Mohand H., Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet. 351:1998;1682
18. Pontesilli O., Kerkhof-Garde S., Pakker N.G., Notermans D.W., Roos M.T., Klein M.R., Danner S.A., Miedema F. Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection. Immunol Lett. 66:1999;213
19. Pontesilli O., Kerkhof-Garde S., Notermans D.W., Foudraine N.A., Roos M.T., Klein M.R., Danner S.A., Lange J.M., Miedema F. Functional T cell reconstitution and human immunodeficiency virus-1- specific cell-mediated immunity during highly active antiretroviral therapy. J Infect Dis. 180:1999;76
20. Pitcher C.J., Quittner C., Peterson D.M., Connors M., Koup R.A., Maino V.C., Picker L.J. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med. 5:1999;518
21. Conners M., Kovacs J.A., Krevat S., Gea-Banacloche J.C., Sneller M.C., Flanigan M., Metcalf J.A., Walker R.E., Falloon J., Baseler M., Stevens R., Feuerstein I., Masur H., Lane H.C. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med. 3:1997;533
22. Dalod M., Harzic M., Pellegrin I., Dumon B., Hoen B., Sereni D., Deschemin J.C., Levy J.P., Venet A., Gomard E. Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy. J Infect Dis. 178:1998;61
23. Barron M.A., Blyveis N., Palmer B.E., MaWhinney S., Wilson C.C. Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J Infect Dis. 187:2003;26
24. Altfeld M., Rosenberg E.S., Shankarappa R., Mukherjee J.S., Hecht F.M., Eldridge R.L., Addo M.M., Poon S.H., Phillips M.N., Robbins G.K., Sax P.E., Boswell S., Kahn J.O., Brander C., Goulder P.J., Levy J.A., Mullins J.I., Walker B.D. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 193:2001;169
25. Moss R.B., Giermakowska W.K., Wallace M.R., Savary J.R., Jensen F.C., Carlo D.J. Cell-mediated immune responses to autologous virus in HIV-1- seropositive individuals after treatment with an HIV-1 immunogen. AIDS. 14:2000;2475
26. Kroon F.P., Beersma M.F., Kroes A.C., Groeneveld P.H., van Dissel J.T. Vaccination and HIV-1 replication during highly active antiretroviral therapy. AIDS. 13:1999;135
27. Barouch D.H., Craiu A., Kuroda M.J., Schmitz J.E., Zheng X.X., Santra S., Frost J.D., Krivulka G.R., Lifton M.A., Crabbs C.L., Heidecker G., Perry H.C., Davies M.E., Xie H., Nickerson C.E., Steenbeke T.D., Lord C.I., Montefiori D.C., Strom T.B., Shiver J.W., Lewis M.G., Letvin N.L. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc Natl Acad Sci U S A. 97:2000;4192
28. Pinto L.A., Berzofsky J.A., Fowke K.R., Little R.F., Merced-Galindez F., Humphrey R., Ahlers J., Dunlop N., Cohen R.B., Steinberg S.M., Nara P., Shearer G.M., Yarchoan R. HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients. AIDS. 13:1999;2003
29. Lu W., Wu X., Lu Y., Guo W., Andrieu J.M. Therapeutic dendritic-cell vaccine for simian AIDS. Nat Med. 9:2003;27
30. Pulendran B., Banchereau J., Burkeholder S., Kraus E., Guinet E., Chalouni C., Caron D., Maliszewski C., Davoust J., Fay J., Palucka K. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol. 165:2000;566
31. Ishioka G.Y., Fikes J., Qin M., Gianfrani C., Chesnut R.W., Kahn L.E., Streeter P.R., Woulfe S.L., Sette A. Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function. Vaccine. 19:2001;3710
32. Kahn L.E., Farese A.M., MacVittie T.J. Progenipoietin G promotes in vivo expansion of hematopoietic progenitor cells in mice and in nonhuman primates. Blood. 90:1997;58a
33. Fleming W.H., Mulcahy J.M., McKearn J.P., Streeter P.R. Progenipoietin-1 a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells. Exp Hematol. 29:2001;943
34. Streeter P.R., Minster N.I., Kahn L.E., Hood W.F., Vickery L.E., Thurman T.L., Monahan J.B., Welply J.K., McKearn J.P., Woulfe S.L. Progenipoietins biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor. Exp Hematol. 29:2001;41
35. Farese A.M., Casey D.B., Vigneulle R.M., Smith W.G., Woulfe S.L., MacVittie T.J. Progenipoietin, in an abbreviated (QOD) schedule, stimulates superior multilineage hematopoietic recovery as compared to Flt-3 and/or G-CSF. Blood. 94:1999;48a
36. Ladd A., Farese A., Redinger C., Douek D., Mann D., Woulfe S., MacVittie T. Radiation-induced T cell deficiencies can be abbreviated with administration of the dual growth factor receptor agonist progenipoietin. Blood. 98:2001;296a
37. Gougeon M.L., Garcia S., Heeney J., Tschopp R., Lecoeur H., Guetard D., Rame V., Dauguet C., Montagnier L. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses. 9:1993;553
38. Heeney J. AIDS a disease of impaired Th-cell renewal? Immunol Today. 16:1995;515
39. Gold L.H., Fox H.S., Henriksen S.J., Buchmeier M.J., Weed M.R., Taffe M.A., Huitron-Resendiz S., Horn T.F., Bloom F.E. Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J Med Primatol. 27:1998;104
40. Kestler H, Kodama T, Ringler D, Marthas M, Pedersen N, Lackner A, Regier D, Sehgal P, Daniel M, King N, Desrosiers R: Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109, 1990
41. Niphuis H., Dubbes R.H., ten Haaft P.J., Koornstra W.H., Bontrop R.E., Cranage M.P., Heeney J.L. Infectivity and virulence of cell-associated SIVmac after single passage in vivo. AIDS. 8:1994;1730
42. Violand B.N., Minnerly J.C., Feng Y.G., Polazzi J.O., Mathis K.J., Thomas K.E., Zeng D.L. Purification and characterization of progenipoietins produced in Escherichia coli. Protein Expr Purif. 26:2002;275
43. Johnson P.R., Hirsch V.M. Pathogenesis of AIDS the non-human primate model. AIDS. 5:1991;S43
44. Koopman G., Niphuis H., Newman W., Kishimoto T.K., Maino V.C., Heeney J.L. Decreased expression of IL-2 in central and effector CD4 memory cells during progression to AIDS in rhesus macaques. AIDS. 15:2001;2359
45. Marandin A., Katz A., Oksenhendler E., Tulliez M., Picard F., Vainchenker W., Louache F. Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood. 88:1996;4568
46. Geissler R.G., Ottmann O.G., Kleiner K., Mentzel U., Bickelhaupt A., Hoelzer D., Ganser A. Decreased haematopoietic colony growth in long-term bone marrow cultures of HIV-positive patients. Res Virol. 144:1993;69
47. Zauli G., Re M.C., Davis B., Sen L., Visani G., Gugliotta L., Furlini G., La Placa M. Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood. 79:1992;2680
48. Hillyer C.D., Klumpp S.A., Hall J.M., Lackey D.A. 3rd, Ansari A.A., McClure H.M. Multifactorial etiology of anemia in SIV-infected rhesus macaques decreased BFU-E formation, serologic evidence of autoimmune hemolysis, and an exuberant erythropoietin response. J Med Primatol. 22:1993;253
49. Nielsen S.D., Sorensen T.U., Aladdin H., Ersboll A.K., Mathiesen L., Ullum H., Gerstoft J., Nielsen J.O., Pedersen B.K. The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals. Scand J Immunol. 52:2000;298
50. Isgro A., Mezzaroma I., Aiuti A., De Vita L., Franchi F., Pandolfi F., Alario C., Ficara F., Riva E., Antonelli G., Aiuti F. Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 16:2000;1471
51. Miles S.A., Mitsuyasu R.T., Moreno J., Baldwin G., Alton N.K., Souza L., Glaspy J.A. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood. 77:1991;2109
52. Armstrong W.S., Kazanjian P. Use of cytokines in human immunodeficiency virus-infected patients colony-stimulating factors, erythropoietin, and interleukin-2. Clin Infect Dis. 32:2001;766
53. Bucur S.Z., Lackey D.A. 3rd, Adams J.W., Lee M.E., Villinger F., Mayne A., Bray R.A., Winton E.F., Novembre F., Strobert E.A., De Rosayro J., Dailey P.J., Ansari A.A., Hillyer C.D. Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques. AIDS Res Hum Retroviruses. 14:1998;651
54. MacVittie T.J., Farese A.M., Smith W.G., Baum C.M., Burton E., McKearn J.P. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression. Blood. 95:2000;837
55. Sudo Y., Shimazaki C., Ashihara E., Kikuta T., Hirai H., Sumikuma T., Yamagata N., Goto H., Inaba T., Fujita N., Nakagawa M. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice. Blood. 89:1997;3186
56. Berg E.L., Robinson M.K., Warnock R.A., Butcher E.C. The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor. J Cell Biol. 114:1991;343
57. Hamann A., Jablonski-Westrich D., Scholz K.U., Duyvestijn A., Butcher E.C., Thiele H.G. Regulation of lymphocyte homing (I) alterations in homing receptor expression and organ-specific HEV-binding of lymphocytes upon activation. Immunology. 140:1988;737
58. Roederer M., De Rosa S.C., Watanabe N., Herzenberg L.A. Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation. Semin Immunol. 9:1997;389